SciSparc Ltd. (SPRC) stock

SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30

$0.35−0.00 (-0.62%)

Close on Nov 13, 2026Market cap $129.04KP/E 0.0Yield –

SciSparc cash

Cash and short-term investments held at the end of each period.

SciSparc's cash was $4.44M at Jun 30, 2026. For fiscal 2025 it was $4.59M, up 198.1% from the year before. Over ten years it grew 11.3% a year on average. The highest annual figure on record is $9.20M in fiscal 2017.

Annual cash

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$4.59M	+198.1%
FY2024	Dec 31, 2024	$1.54M	-25.8%
FY2023	Dec 31, 2023	$2.08M	-41.9%
FY2022	Dec 31, 2022	$3.57M	-48.0%
FY2021	Dec 31, 2021	$6.88M	+253.3%
FY2020	Dec 31, 2020	$1.95M	+123.7%
FY2019	Dec 31, 2019	$870.00K	-41.4%
FY2018	Dec 31, 2018	$1.49M	-83.8%
FY2017	Dec 31, 2017	$9.20M	+1260.2%
FY2016	Dec 31, 2016	$676.00K	-57.0%
FY2015	Dec 31, 2015	$1.57M	+901.9%
FY2014	Dec 31, 2014	$157.00K	–

Quarterly cash

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	$4.44M	+1660.3%
Q4 FY2025	Dec 31, 2025	$4.59M	+121.1%
Q2 FY2025	Jun 30, 2025	$1.55M	-25.8%
Q4 FY2024	Dec 31, 2024	$1.54M	-56.9%
Q2 FY2024	Jun 30, 2024	$252.00K	-98.1%
Q4 FY2023	Dec 31, 2023	$2.08M	-69.8%
Q2 FY2023	Jun 30, 2023	$2.08M	-72.6%
Q4 FY2022	Dec 31, 2022	$3.57M	+83.7%
Q2 FY2022	Jun 30, 2022	$12.95M	+8889.6%
Q4 FY2021	Dec 31, 2021	$6.88M	+690.2%
Q2 FY2021	Jun 30, 2021	$7.59M	+376.5%
Q4 FY2020	Dec 31, 2020	$1.95M	+31.0%
Q2 FY2020	Jun 30, 2020	$144.00K	-97.2%
Q4 FY2019	Dec 31, 2019	$870.00K	-88.4%
Q2 FY2019	Jun 30, 2019	$1.59M	-82.7%
Q4 FY2018	Dec 31, 2018	$1.49M	-87.4%
Q2 FY2018	Jun 30, 2018	$5.10M	-57.7%
Q1 FY2018	Mar 31, 2018	$7.51M	+1010.8%
Q4 FY2017	Dec 31, 2017	$9.20M	+484.6%
Q2 FY2017	Jun 30, 2017	$11.78M	+7405.7%
Q1 FY2017	Mar 31, 2017	$12.05M	–
Q4 FY2016	Dec 31, 2016	$676.00K	–
Q4 FY2015	Dec 31, 2015	$1.57M	–
Q4 FY2014	Dec 31, 2014	$157.00K	–